Ultra Market Research | Global Bioresorbable Stents Market
Global Bioresorbable Stents Market
Report ID : 888
Category : Medical-Devices,Global
No Of Pages : 139
Published on: December 2024
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Global Bioresorbable Stents Market
Introduction Global Bioresorbable Stents Market is one of the most significant transformative innovations in the field of cardiovascular, as they momentarily provide scaffolding to keep the patency of vessels and gradually dissolve after it is accomplished. The stents are used for the treatment of coronary artery diseases and peripheral arterial diseases to reduce the risk of late stent thrombosis complication. With increasing global cases of cardiovascular diseases, the market has witnessed tremendous growth, along with advancements in material science and the growing trend toward minimal interventions. The global bioresorbable stents market is seen to be large enough to surpass USD 1.5 billion by the year 2024, reaping a robust CAGR due to technological innovations, favorable regulatory approvals, and healthcare awareness. Emerging trends include the development of next-generation stents with improved mechanical properties and bioabsorption rates, ensuring better patient outcomes.
Segmentation Material Type • Polymer-Based Stents o Poly-L-lactic Acid (PLLA) o Polycarbonate o Others • Metal-Based Stents o Magnesium Alloy o Zinc Alloy • Hybrid Stents o Polymer-Coated Metal o Biodegradable Polymer Layers
Absorption Rate • Fast-Absorbing Stents o <1 Year o 1–2 Years • Slow-Absorbing Stents o 2–3 Years o 3 Years
Application • Coronary Artery Disease o Acute Coronary Syndrome o Stable Angina • Peripheral Artery Disease o Lower Limb Arteries o Renal Arteries
End-User • Hospitals o Cardiac Departments o Emergency Care Units • Ambulatory Surgical Centers o Multi-Specialty Centers o Standalone Centers • Cardiac Specialty Clinics o Chain Clinics o Independent Clinics
Geography • North America o United States o Canada • Europe o Germany o United Kingdom o France • Asia-Pacific o China o Japan o India • Latin America o Brazil o Mexico • Middle East & Africa o GCC o South Africa
List of Market Players 1. Abbott Laboratories (United States) 2. Biotronik (Germany) 3. Boston Scientific Corporation (United States) 4. Elixir Medical Corporation (United States) 5. Medtronic PLC (Ireland) 6. Terumo Corporation (Japan) 7. Kyoto Medical Planning Co., Ltd. (Japan) 8. REVA Medical, Inc. (United States) 9. Arterial Remodeling Technologies (France) 10. Lepu Medical Technology Co., Ltd. (China) 11. Amaranth Medical Inc. (United States) 12. S3V Vascular Technologies (India) 13. Lifetech Scientific (China) 14. Alvimedica (Turkey) 15. Meril Life Sciences (India)
Drivers Increasing incidence of cardiovascular diseases worldwide primarily fuels the growth of the Bioresorbable Stents Market. Increased adoption of minimally invasive procedures in coronary artery treatment and peripheral artery management has fueled the demand for such advanced stents. Further, growing interest in bioresorbable stents from the patients to minimize the occurrence of long-term complications, such as restenosis and late thrombosis, has contributed to its demand. Technological development with high radial strength in stents and better absorption kinetics contributes much to the growing markets. Positive regulatory environment support combined with inclusion within the purview of health insurance contributes significantly to increased accessibility, consequently raising demand.
Restraints Despite its potential, the Bioresorbable Stents Market faces many challenges. The high cost of these stents is a significant deterrent to widespread use, especially in low- and middle-income regions. Lack of data on long-term efficacy and occasional adverse events, such as stent collapse or arterial recoil, cause concern among cardiologists. Complex manufacturing processes, coupled with stringent regulatory approvals, slow down product launches. Furthermore, competition from well-established metallic stents offering cost efficiency and proven efficacy is yet another factor hindering the market's growth curve.
Opportunity GlobalBioresorbable Stents Market presents opportunities through advancements in bioengineering and material science. Development of next-generation stents with enhanced mechanical strength, better absorption timelines, and minimal inflammatory response offers immense potential. Expansion in emerging markets such as Asia-Pacific and Latin America, backed by improving healthcare infrastructure and increased awareness, further fuels growth. Design and development of personalized stents with med-tech firms and research institutes: collaborations open up other opportunities. Regulatory approvals of new designs of stents sustain the interest in the market of the product.
Trend Latest trends in the Bioresorbable Stents Market is the shift towards hybrid stent designs that combine the benefits of bioresorbable polymers and metallic scaffolds. Innovations such as AI-driven modeling for custom-fit stents and advanced imaging techniques for accurate deployment have started to gain traction. Incorporation of anti-inflammatory and drug-eluting coatings to reduce restenosis rates has been another significant development. Moreover, the rise of telemedicine has facilitated remote consultations, making stent-based treatments more accessible.
Key Target Audience • Hospitals and Healthcare Providers • Cardiology Specialists • Medical Device Distributors • Regulatory Authorities • Research and Academic Institutes
Frequently Asked Questions (FAQ's)
The market focuses on stents that dissolve naturally in the body after maintaining arterial patency.
They are used for treating coronary and peripheral artery diseases.
North America dominates, but Asia-Pacific is the fastest-growing region.
High costs, regulatory hurdles, and limited long-term efficacy data.
Companies like Abbott, Boston Scientific, and Medtronic lead the industry.
1. Introduction 1.1 Report Description 1.2 Research Methodology 1.2.1 Data Mining 1.2.2 Market Modeling and Forecasting 1.2.3 Data Validation 1.2.4 Industry Analysis
2. Market Dashboard
3. Market Overview 3.1 Market Definition and Scope 3.2 Market Segmentation 3.2.1 By Material Type • Polymer-Based Stents o Poly-L-lactic Acid (PLLA) o Polycarbonate o Others • Metal-Based Stents o Magnesium Alloy o Zinc Alloy • Hybrid Stents o Polymer-Coated Metal o Biodegradable Polymer Layers 3.2.2 By Absorption Rate • Fast-Absorbing Stents o <1 Year o 1–2 Years • Slow-Absorbing Stents o 2–3 Years o 3 Years 3.2.3 By Application • Coronary Artery Disease o Acute Coronary Syndrome o Stable Angina • Peripheral Artery Disease o Lower Limb Arteries o Renal Arteries 3.2.4 By End-User • Hospitals o Cardiology Departments o Emergency Care Units • Ambulatory Surgical Centers o Multi-Specialty Centers o Standalone Centers • Cardiac Specialty Clinics o Chain Clinics o Independent Clinics 3.2.5 By Geography • North America • Europe • Asia-Pacific • Latin America • Middle East & Africa 3.3 Market Dynamics 3.3.1 Drivers 3.3.2 Restraints 3.3.3 Opportunities 3.3.4 Challenges
4. Global Bioresorbable Stents Market by Material Type 4.1 Introduction 4.2 Market Size and Growth Rate by Material Type (2024–2030) 4.2.1 Polymer-Based Stents 4.2.2 Metal-Based Stents 4.2.3 Hybrid Stents
5. Global Bioresorbable Stents Market by Absorption Rate 5.1 Introduction 5.2 Market Size and Growth Rate by Absorption Rate (2024–2030) 5.2.1 Fast-Absorbing Stents 5.2.2 Slow-Absorbing Stents
6. Global Bioresorbable Stents Market by Application 6.1 Introduction 6.2 Market Size and Growth Rate by Application (2024–2030) 6.2.1 Coronary Artery Disease 6.2.2 Peripheral Artery Disease
7. Global Bioresorbable Stents Market by End-User 7.1 Introduction 7.2 Market Size and Growth Rate by End-User (2024–2030) 7.2.1 Hospitals 7.2.2 Ambulatory Surgical Centers 7.2.3 Cardiac Specialty Clinics
8. Global Bioresorbable Stents Market by Geography 8.1 Introduction 8.2 Market Size and Growth Rate by Region (2024–2030) 8.2.1 North America • United States • Canada 8.2.2 Europe • Germany • United Kingdom • France • Rest of Europe 8.2.3 Asia-Pacific • China • Japan • India • Southeast Asia • Rest of Asia-Pacific 8.2.4 Latin America • Brazil • Mexico • Rest of Latin America 8.2.5 Middle East & Africa • GCC • North Africa • South Africa • Rest of Middle East & Africa
9. Competitive Landscape 9.1 Company Profiles 9.1.1 Abbott Laboratories (United States) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 9.1.2 Boston Scientific Corporation (United States) 9.1.3 Biotronik (Germany) 9.1.4 Elixir Medical Corporation (United States) 9.1.5 Medtronic PLC (Ireland) 9.1.6 Terumo Corporation (Japan) 9.1.7 Kyoto Medical Planning Co., Ltd. (Japan) 9.1.8 REVA Medical, Inc. (United States) 9.1.9 Arterial Remodeling Technologies (France) 9.1.10 Lepu Medical Technology Co., Ltd. (China) 9.1.11 Amaranth Medical Inc. (United States) 9.1.12 S3V Vascular Technologies (India) 9.1.13 Lifetech Scientific (China) 9.1.14 Alvimedica (Turkey) 9.1.15 Meril Life Sciences (India)
10. List of Tables and Figures Tables: • Table 1: Market Size by Material Type (2024–2030) • Table 2: Market Size by Absorption Rate (2024–2030) • Table 3: Market Size by Application (2024–2030) • Table 4: Market Size by Region (2024–2030) Figures: • Figure 1: Global Bioresorbable Stents Market Dynamics • Figure 2: Regional Market Share Analysis (2024) • Figure 3: Market Value Chain
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of Global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of Global Bioresorbable Stents Market and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of Global Bioresorbable Stents Market for the past year and forecasts for the next six years. Global Bioresorbable Stents Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different Global Bioresorbable Stents Market categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for Global Bioresorbable Stents Market from different application industries in different regions.
Segmentation Material Type • Polymer-Based Stents o Poly-L-lactic Acid (PLLA) o Polycarbonate o Others • Metal-Based Stents o Magnesium Alloy o Zinc Alloy • Hybrid Stents o Polymer-Coated Metal o Biodegradable Polymer Layers
Absorption Rate • Fast-Absorbing Stents o <1 Year o 1–2 Years • Slow-Absorbing Stents o 2–3 Years o 3 Years
Application • Coronary Artery Disease o Acute Coronary Syndrome o Stable Angina • Peripheral Artery Disease o Lower Limb Arteries o Renal Arteries
End-User • Hospitals o Cardiac Departments o Emergency Care Units • Ambulatory Surgical Centers o Multi-Specialty Centers o Standalone Centers • Cardiac Specialty Clinics o Chain Clinics o Independent Clinics
Geography • North America o United States o Canada • Europe o Germany o United Kingdom o France • Asia-Pacific o China o Japan o India • Latin America o Brazil o Mexico • Middle East & Africa o GCC o South Africa
